Adventia Pharma joins the fight against cancer by signing a collaboration agreement with the AECC aimed at preventing the disease.

Adventia Pharma and the Spanish Association Against Cancer (AECC) have signed a framework collaboration agreement in order to join forces in the fight against cancer.

The director of national economic sustainability, Doña Julia Sánchez and Jose Javier Díaz Ortega, CEO of Adventia Pharma, have signed a collaboration agreement through which both institutions agree to work together on actions aimed at preventing the fight against cancer. The agreement signed by both parties will have a renewable duration of one year.

The objective of this agreement is to inform the population about how to prevent and detect the disease early, in addition to improving the quality of life of patients. The basis of this union is to serve as a speaker for the AECC and promote healthy lifestyle habits within the framework of the prevention of this disease.

"For Adventia Pharma this collaboration represents another commitment to our commitment to ensure the health of cancer patients, always aimed at improving their quality of life, which is why we work every day", según explica José Díaz, CEO de Adventia Pharma.

The pillars of this new relationship are based on informing, raising awareness, supporting and making this disease visible. As well as promoting campaigns and actions jointly and collaborating in the fight against cancer.